UniProt/SwissProt ID: | VIGLN_HUMAN |
Description: | high density lipoprotein binding protein [Source:HGNC Symbol;Acc:4857] |
Location: | chr2 q37.3 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T671 | NSLIGtKGRLI | HPRD | |
S667 | AKLHNsLIGTK | KH_1 | PhosphoSitePlus |
S1223 | EAKAPsRGFVV | PhosphoSitePlus; HPRD; phosphoELM | |
S904 | ITRDFsVQIKF | KH_1 | PhosphoSitePlus |
S31 | VATLNsEEESD | PhosphoSitePlus; HPRD; phosphoELM | |
S368 | SFTVSsVAAPS | KH_1 | PhosphoSitePlus |
T671 | NSLIGtKGRLI | KH_1 | PhosphoSitePlus |
S944 | DCDPGsPRRCD | HPRD; phosphoELM | |
S944 | DCDPGsPRRCD | KH_1 | PhosphoSitePlus |
Y40 | SDPPTyKDAFP | PhosphoSitePlus | |
Y465 | RIKDQyKVSVR | KH_1 | PhosphoSitePlus |
S1252 | SEEFPsFGAQV | PhosphoSitePlus; HPRD | |
T1058 | FKLSVtVDPKY | HPRD | |
T296 | KKKKTtTIAVE | PhosphoSitePlus | |
T111 | EIMQRtGAHLE | PhosphoSitePlus | |
T1058 | FKLSVtVDPKY | KH_1 | PhosphoSitePlus |
S1236 | APWTAsSSEKA | HPRD; phosphoELM | |
S454 | HLIGKsGANIN | KH_1 | PhosphoSitePlus |
Y582 | LVENSySISVP | PhosphoSitePlus | |
S1237 | PWTASsSEKAP | HPRD; phosphoELM | |
S468 | DQYKVsVRIPP | KH_1 | PhosphoSitePlus |
S645 | RSRILsIQKDL | PhosphoSitePlus | |
S1056 | RSFKLsVTVDP | KH_1 | PhosphoSitePlus |
Y437 | INRMDyVEINI | HPRD; phosphoELM | |
T297 | KKKTTtIAVEV | KH_1 | PhosphoSitePlus |
S1246 | APDMSsSEEFP | PhosphoSitePlus | |
Y437 | INRMDyVEINI | KH_1 | PhosphoSitePlus |
S583 | VENSYsISVPI | KH_1 | PhosphoSitePlus |
S581 | DLVENsYSISV | PhosphoSitePlus | |
S126 | KDQGLsIMVSG | HPRD | |
Y1210 | EALQVyMKPPA | PhosphoSitePlus | |
S216 | EVLLIsAEQDK | PhosphoSitePlus; HPRD | |
Y358 | ALTEVyAKANS | PhosphoSitePlus | |
S756 | RKVRDsTGARV | HPRD | |
T1261 | QVAPKtLPWGP | PhosphoSitePlus; HPRD | |
S1056 | RSFKLsVTVDP | HPRD | |
Dephosphorylation site |
VIGLN_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000375837 | D939V | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
ENSP00000312042 | E203Q | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000375836 | G778E | COSMIC | Skin Cancer | 21984974 |
ENSP00000375837 | A1140T | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000312042 | A1140T | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000375836 | D939V | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
ENSP00000375837 | E203Q | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000312042 | D939V | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
ENSP00000375836 | E203Q | BIOMART | Breast Cancer | 21930507, 21930502 |
ENSP00000312042 | K568N | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
ENSP00000375836 | A1140T | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000375836 | K568N | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
ENSP00000312042 | G778E | COSMIC | Skin Cancer | 21984974 |
ENSP00000375837 | G778E | COSMIC | Skin Cancer | 21984974 |
ENSP00000375837 | K568N | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000312042 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Up | 2 | 18646787 |
ENSP00000312042 | Ovarian Cancer | Treatment (cisplatin-sensitive vs. cisplatin-resistant) | cell line | Down | 0.53 | 16319398 |
ENSP00000312042 | Hepatocellular Carcinoma | Metastasis | cell line | Up | 1.8 | 19016532 |
ENSP00000312042 | Breast Cancer | Normal vs. Cancer | tissue | Up | 0.45 | 20739354 |
ENSP00000312042 | Gastric Cancer | Treatment (none vs. drug-resistant) | cell line | Up | 1.4 | 20625496 |
Hyperphosphorylation site |
VIGLN_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
PDPK1_HUMAN | VIGLN_HUMAN | kinase -> substrate | Robert H Newman (2013) |
STK11_HUMAN | VIGLN_HUMAN | kinase -> substrate | Robert H Newman (2013) |
Function Annotation |
KEGG Pathway |
VIGLN_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0005634 | nucleus | IEA | cellular_component |
GO:0006869 | lipid transport | IEA | biological_process |
GO:0008203 | cholesterol metabolic process | IEA | biological_process |
GO:0005886 | plasma membrane | TAS | cellular_component |
GO:0008289 | lipid binding | TAS | molecular_function |
GO:0003723 | RNA binding | IEA | molecular_function |
GO:0034364 | high-density lipoprotein particle | IEA | cellular_component |
GO:0005737 | cytoplasm | IDA | cellular_component |